Physician profile
Jason Katz
NPI 1417081654
$43,847.21
in general payments reported to CMS, 2019-2025
13 companies · $9,476 in 2025
The $9,476 reported for 2025 was more than what 76% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $64.80 · 2021: $442 · 2022: $2,994 · 2023: $4,791 · 2024: $26K · 2025: $9,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $36K · Food and Beverage: $2,154 · Consulting Fee: $1,300 · Travel and Lodging: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $35,700.00 |
| Food and Beverage | $2,153.66 |
| Consulting Fee | $1,300.00 |
| Travel and Lodging | $843.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23,647.54 | 2022-2025 | Lifevest |
| Abiomed | $17,578.63 | 2021-2025 | Impella |
| Abbott Laboratories | $1,671.42 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Cvrx, INC. | $239.34 | 2025 | Barostim Neo System |
| Getinge USA Sales, LLC | $226.48 | 2023-2025 | Cardiohelp, Cardiosave Rescue |
| Teleflex LLC | $132.08 | 2023 | Arrow |
| Astrazeneca Pharmaceuticals LP | $121.22 | 2022 | |
| Angiodynamics, INC. | $58.39 | 2024-2025 | Alphavac |
| Chiesi USA, INC. | $54.18 | 2025 | |
| La Jolla Pharmaceutical Company | $49.00 | 2020 | |
| One Lambda, INC. | $33.63 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $19.76 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $15.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.